HC Wainwright Reaffirms "Buy" Rating for Viking Therapeutics (NASDAQ:VKTX) : vimarsana.com

Viking Therapeutics (NASDAQ:VKTX – Get Free Report)‘s stock had its “buy” rating restated by research analysts at HC Wainwright in a research note issued on Tuesday, Benzinga reports. They presently have a $90.00 target price on the biotechnology company’s stock. HC Wainwright’s price target indicates a potential upside of 6.26% from the stock’s previous close. […]

Related Keywords

Sarah Kathryn Rouan , Greg Zante , Raymond James , Stifel Nicolaus , Jefferies Financial Group , Therapeutics Inc , Us Bancorp , Cetera Advisor Networks , Securities Exchange Commission , Wetzel Investment Advisors Inc , Retirement Group , Viking Therapeutics , Get Free Report , Financial Group , Exchange Commission , Director Sarah Kathryn Rouan , Advisor Networks , Investment Advisors , Gate Manager , Viking Therapeutics Daily ,